RE: Amortisation EBITDA vs EBIT17 Dec 2021 06:24
Hi TheAcc, you're absolutely right I've used accumulated amortisation from 30/06/21 not "for the period" - apologies!
So the picture is rosier - and I agree the revenue growth is what will drive this to PBT profitability (not just EBITDA profitable). My concern was/is that based on my (incorrect) numbers they were far away from achieving that!! Now I'm looking at a more realistic level I am rather relieved as I bought this based on ST recommendation and without doing my own due diligence!
I got the growth in administration costs from Cenkos whose numbers are FY2021 £2.6m cost and FY2022 £3.8m cost. This growth, in turn, I realised relates to the new "Mobile Advertising" service line announced June 2021. This £1.2m are the additional human being costs of operating this new service line and which are a fixed cost - so appear to fall under "Administrative" rather than S&M costs..... Odd, but at least I feel I understand the numbers now. The other point that I had failed to appreciate was that the mViva mobile advertising is a new service line.... going further back I realised that they are adding this in 2021 with a single Indian subsidiary of a European Telco (e.g. Vodafone?) to prove concept and that the revenues will follow and ramp in 2022 and beyond.
Looking at the update 27/09 they believe that the FY2021 revenues are already on target ($7.2m) and anticipating $9m revenue in FY2022. Of that about $2.5m is recurring revenue; so the remainder is$6.5m for 2022 and they have a pipeline of $18m of opportunities as at end September 21.... including expansion to non-telecom customers - ad agencies, banks and so on.
I can now see how that the "worsening" PBT for 2022 of -$1.1m is an investment.... and it could be zero in FY2022 if their revenue surprises by around 11% to the upside.... And worst case with further growth FY2023 should be PBT profitable. Once it's on a track to PBT profitable, low ARR multiples make this an exciting buy, in my opinion.
NB My numbers came from Cenkos and I got those from research-tree dot com. (sorry I can't share a direct link as they don't allow)